PROFUND ADVISORS LLC – BioMarin Pharmaceutical Inc. Transaction History
PROFUND ADVISORS LLC portfolio value:
$1.71M
portfolio value
PROFUND ADVISORS LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -4.32% | -914 shares | -38K | $84.77 | 20.22K |
Q2 2022 | share | Decrease | -7.57% | -1.73K shares | -11K | $82.87 | 21.13K |
Q1 2022 | share | Decrease | -9.41% | -2.37K shares | -467K | $77.1 | 22.87K |
Q4 2021 | share | Decrease | -15.09% | -4.48K shares | -68K | $89.08 | 25.24K |
Q3 2021 | share | Decrease | -4.67% | -1.45K shares | -305K | $77.29 | 29.73K |
Q2 2021 | share | Decrease | -2.63% | -843 shares | 184K | $83.44 | 31.18K |
Q1 2021 | share | Decrease | -13.40% | -4.95K shares | -824K | $75.51 | 32.03K |
Q4 2020 | share | Decrease | -16.32% | -7.21K shares | -120K | $87.69 | 36.98K |
Q3 2020 | share | Decrease | -11.65% | -5.83K shares | -2.80M | $76.08 | 44.19K |
Q2 2020 | share | Increase | +15.38% | 6.66K shares | 2.50M | $123.34 | 50.02K |
Q1 2020 | share | Decrease | -25.07% | -14.50K shares | -1.22M | $84.5 | 43.36K |
Q4 2019 | share | Increase | +11.62% | 6.02K shares | 1.39M | $84.55 | 57.86K |
Q3 2019 | share | Decrease | -4.84% | -2.63K shares | -1.17M | $67.4 | 51.84K |
Q2 2019 | share | Decrease | -7.72% | -4.55K shares | -579K | $85.65 | 54.48K |
Q1 2019 | share | Increase | +1.28% | 747 shares | 281K | $88.83 | 59.04K |
Q4 2018 | share | Decrease | -18.82% | -13.51K shares | -1.99M | $85.15 | 58.29K |
Q3 2018 | share | Increase | +9.88% | 6.45K shares | 807K | $96.97 | 71.80K |
Q2 2018 | share | Decrease | -3.94% | -2.67K shares | 641K | $94.2 | 65.35K |
Q1 2018 | share | Decrease | -7.53% | -5.54K shares | -1.04M | $81.07 | 68.03K |
Q4 2017 | share | Decrease | -10.00% | -8.17K shares | -1.04M | $89.17 | 73.57K |
Q3 2017 | share | Increase | +7.91% | 5.98K shares | 727K | $93.07 | 81.74K |
Q2 2017 | share | Decrease | -4.23% | -3.34K shares | -63K | $90.82 | 75.76K |
Q1 2017 | share | Decrease | -6.47% | -5.46K shares | -62K | $87.78 | 79.10K |
Q4 2016 | share | Decrease | -12.09% | -11.63K shares | -1.89M | $82.84 | 84.57K |
Q3 2016 | share | Increase | +1.00% | 949 shares | 1.49M | $92.52 | 96.20K |
Q2 2016 | share | Decrease | -3.66% | -3.61K shares | -744K | $77.8 | 95.25K |
Q1 2016 | share | Decrease | -18.90% | -23.04K shares | -4.61M | $82.48 | 98.87K |